All Search Results
-
An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Patients With High-Risk Melanoma (KEYNOTE-942)
A Phase 2 Randomized Study of Adjuvant Immunotherapy With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab Versus Pembrolizumab Alone After Complete Resection of High-Risk Melanoma
-
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
A Phase 3 Randomized Non-Inferiority Study of Carboplatin and Vincristine Versus Selumetinib (NSC# 748727) in Newly Diagnosed or Previously Untreated Low-Grade Glioma (LGG) Not Associated With BRAFV600E Mutations or Systemic Neurofibromatosis Type 1 (NF1)
-
Orlando Health Heart & Vascular Institute is first in the state to implant new defibrillator for patients at risk for sudden cardiac arrest
New technology gives high risk patients timely treatment when minutes matter most.
-
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients with TNBC Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05)
A Randomized, Open-label, Phase 3 Study of Adjuvant Sacituzumab Govitecan and Pembrolizumab Versus Treatment of Physician's Choice in Patients with Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy
-
A Day in the Life of an ER Nurse
As an emergency room nurse at Orlando Health I get to make a difference in a patient’s life at a time when they are most in need of care. I'd even say it's one of the rare nursing specialties where you can physically see the difference you've made for a patient almost immediately. Whether it's something simple, such as helping a patient relieve the pain of a migraine, or something major, such as helping deliver a child or resuscitating a patient who came in without a pulse, you see the impact right away.
-
A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma
A Randomized Phase 3 Trial of Vinorelbine, Dactinomycin, and Cyclophosphamide (VINO-AC) Plus Maintenance Chemotherapy With Vinorelbine and Oral Cyclophosphamide (VINO-CPO) vs Vincristine, Dactinomycin and Cyclophosphamide (VAC) Plus VINO-CPO Maintenance in Patients With High Risk Rhabdomyosarcoma (HR-RMS)
-
Why am I so tired and what can I do about it? How to combat the most common symptom of multiple sclerosis
Fatigue occurs in up to 80% of patients with Multiple Sclerosis. It is believed to be related to the impaired nerve conduction which occurs as a result of the damaged myelin and axons (nerves). It is by far the most common symptom of MS and is one of the leading factors in persons leaving the workforce.
-
Retrospective Analysis of Outpatient Chemotherapy Administration and Subsequent Unplanned Emergency Department or Inpatient Admissions
Retrospective Analysis of Outpatient Chemotherapy Administration and Subsequent Unplanned Emergency Department or Inpatient Admissions
-
A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma
A Phase 3 Randomized Study of Selumetinib Versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma (LGG)
-
Understanding the Risks for Concussions in Soccer
As we look forward to this summer’s 2018 FIFA World Cup, we should understand that being a champion can have its costs. We often hear about concussions in football, but soccer also comes with its own risk of serious head injuries.